Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney
NCT06214000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 178
Last updated 2024-03-13
Summary
In France, the second cancer plan of 2009-2013 aimed to strengthen the role of MT by putting it back at the center of patient monitoring, in particular by asking "regional health agencies to encourage and support local experiments" which aim for better coordination between the city and the hospital. The third cancer plan for 2014-2019 insists on this measure because it had proven to be unproductive, and recommends, in addition to the creation of a nurse dedicated to the coordination of care between community medicine and the hospital, the creation of a direct telephone line to reach the hospital medical team. This measure is mainly aimed at the follow-up of certain cancers that do not require the technical support of the hospital, as is the case in the post-operative follow-up of RCC and CaP, where the additional examinations carried out during follow-up are carried out in the city.
The research hypothesis is that this new method of monitoring had a positive impact on care in terms of quality, accessibility, organization and costs.
Conditions
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-20
- Primary Completion
- 2022-06-21
- Completion
- 2022-06-21
Countries
- France
Study Locations
More Related Trials
-
PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma
NCT00427817 ·Status: COMPLETED
-
PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment
NCT04298112 ·Status: COMPLETED
-
Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy
NCT04773821 ·Status: UNKNOWN ·Phase: NA
-
Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part IIB
NCT05200039 ·Status: COMPLETED
-
Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer
NCT06600802 ·Status: RECRUITING ·Phase: NA
-
Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study
NCT01797692 ·Status: COMPLETED ·Phase: NA
-
Biological Markers and Advanced Imaging for Prostate Cancer Progression in Active Surveillance
NCT06866041 ·Status: RECRUITING ·Phase: NA
-
Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program
NCT01786031 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer
NCT07152067 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Timing of Post-prostatectomy PSMA Imaging
NCT05008900 ·Status: COMPLETED ·Phase: PHASE2
-
Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI
NCT04063800 ·Status: COMPLETED
-
Prospective Prostate Cancer and Patient-reported Outcomes Registry
NCT04694924 ·Status: RECRUITING
-
Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer
NCT03531099 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer
NCT02516995 ·Status: COMPLETED ·Phase: NA
-
An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum
NCT05384002 ·Status: COMPLETED
-
Epidemiologic and Genetic Study on Familial Prostate Cancer
NCT01221168 ·Status: RECRUITING
-
Functional Medical Imaging Quantization in Prostate Cancer
NCT03376360 ·Status: COMPLETED
-
Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer
NCT04686188 ·Status: UNKNOWN
-
Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning™ and MRI
NCT01857037 ·Status: COMPLETED ·Phase: NA
-
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
NCT03585114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Medical and Economic Evaluation for Intermediate-risk Prostate Cancer
NCT02271659 ·Status: UNKNOWN ·Phase: NA
-
Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7
NCT05622162 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer
NCT02869282 ·Status: WITHDRAWN
-
Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer
NCT06657131 ·Status: RECRUITING
-
Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors
NCT02957357 ·Status: COMPLETED